TuHURA Biosciences Files 8-K: Officer Changes & Other Events
Ticker: HURA · Form: 8-K · Filed: 2026-04-08T16:15:18-04:00
Sentiment: neutral
Topics: corporate-governance, filing-update
TL;DR
TuHURA 8-K filed: Director/Officer changes, other events on 4/2. Check for exec comp details.
AI Summary
TuHURA Biosciences, Inc./NV filed an 8-K on April 8, 2026, reporting on the departure of a director or officer, other events, and financial statements/exhibits. The filing includes details on compensatory arrangements for certain officers and other events that occurred on April 2, 2026.
Why It Matters
This filing indicates potential shifts in the company's leadership or significant operational updates that could impact its strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors or officers, especially if unexpected, can signal internal issues or strategic shifts that may carry risks.
Key Players & Entities
- TuHURA Biosciences, Inc./NV (company) — Filer of the 8-K report
- 0001498382 (company) — CIK number for TuHURA Biosciences, Inc./NV
- 2026-04-08 (date) — Filing date of the 8-K
- 2026-04-02 (date) — Period of report for the 8-K
FAQ
What specific officer or director departed from TuHURA Biosciences, Inc./NV?
The filing indicates Item 5.02 pertains to the 'Departure of Directors or Certain Officers,' but the specific names are not detailed in the provided summary text.
What were the 'Other Events' reported by TuHURA Biosciences on April 2, 2026?
The filing mentions 'Item 8.01: Other Events' occurred on April 2, 2026, but the specific nature of these events is not detailed in the provided summary text.
What is the significance of Item 5.02 in this 8-K filing?
Item 5.02 covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is the filing date and the period of report for this 8-K?
The filing date is April 8, 2026, and the period of report is April 2, 2026.
Where is TuHURA Biosciences, Inc./NV located?
The company's mailing and business address is 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612.
From the Filing
EDGAR Filing Documents for 0001193125-26-147660 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-147660 Filing Date 2026-04-08 Accepted 2026-04-08 16:15:18 Documents 12 Period of Report 2026-04-02 Items Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K d131347d8k.htm iXBRL 8-K 31380 2 EX-99.1 d131347dex991.htm EX-99.1 118244 Complete submission text file 0001193125-26-147660.txt 288480 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA hura-20260402.xsd EX-101.SCH 2854 4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hura-20260402_lab.xml EX-101.LAB 17992 5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hura-20260402_pre.xml EX-101.PRE 11263 16 EXTRACTED XBRL INSTANCE DOCUMENT d131347d8k_htm.xml XML 3719 Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600 TuHURA Biosciences, Inc./NV (Filer) CIK : 0001498382 (see all company filings) EIN. : 990360497 | State of Incorp.: NV | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 26848297 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)